Michael D. Dake
Publication Details
-
Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
J Vasc Interv Radiol. 2002; (7): 703-7
Therapeutic angiogenesis represents a new paradigm for treatment of ischemic vascular syndromes. However, vascular endothelial growth factor (VEGF) enhances the rate and degree of plaque formation. This study evaluates the potential to block these effects nonspecifically with paclitaxel or specifically with angiostatin.
Help